Thailand - Delayed Quote THB

The Klinique Medical Clinic Public Company Limited (KLINIQ.BK)

Compare
26.25
-0.50
(-1.87%)
At close: 4:39:52 PM GMT+7
Loading Chart for KLINIQ.BK
DELL
  • Previous Close 26.75
  • Open 26.50
  • Bid --
  • Ask --
  • Day's Range 25.75 - 26.75
  • 52 Week Range 25.25 - 45.25
  • Volume 784,206
  • Avg. Volume 433,714
  • Market Cap (intraday) 5.885B
  • Beta (5Y Monthly) 0.12
  • PE Ratio (TTM) 19.59
  • EPS (TTM) 1.34
  • Earnings Date --
  • Forward Dividend & Yield 1.40 (4.59%)
  • Ex-Dividend Date Aug 29, 2024
  • 1y Target Est 42.53

The Klinique Medical Clinic Public Company Limited provides skin medical treatment services under the Klinique brand name in Thailand. Its services include face lift, acne and acne scars, skin tightening, filler, fat dissolving injection, laser hair removal, skin treatment, skin injection, Mesoface, and Mesotua, as well as nose, eye, and facial surgery. The company also sells cosmetics and cosmeceutical products. The Klinique Medical Clinic Public Company Limited was incorporated in 2017 and is based in Bangkok, Thailand.

www.theklinique.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KLINIQ.BK

View More

Performance Overview: KLINIQ.BK

Trailing total returns as of 1/30/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

KLINIQ.BK
19.23%
MSCI WORLD
3.62%

1-Year Return

KLINIQ.BK
31.86%
MSCI WORLD
19.07%

3-Year Return

KLINIQ.BK
27.08%
MSCI WORLD
28.21%

5-Year Return

KLINIQ.BK
27.08%
MSCI WORLD
62.35%

Compare To: KLINIQ.BK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KLINIQ.BK

View More

Valuation Measures

Annual
As of 1/29/2025
  • Market Cap

    5.88B

  • Enterprise Value

    5.83B

  • Trailing P/E

    19.53

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.11

  • Price/Book (mrq)

    3.64

  • Enterprise Value/Revenue

    2.09

  • Enterprise Value/EBITDA

    9.14

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.36%

  • Return on Assets (ttm)

    7.84%

  • Return on Equity (ttm)

    17.74%

  • Revenue (ttm)

    2.63B

  • Net Income Avi to Common (ttm)

    298.3M

  • Diluted EPS (ttm)

    1.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    872.99M

  • Total Debt/Equity (mrq)

    34.90%

  • Levered Free Cash Flow (ttm)

    -78.76M

Research Analysis: KLINIQ.BK

View More

Company Insights: KLINIQ.BK

Research Reports: KLINIQ.BK

View More

People Also Watch